OBJECTIVE: Physical activity (PA) may reduce the risk of coronary heart disease (CHD) by inducing beneficial changes in several risk factors. We studied the associations between PA and a range of risk markers of CHD in young adults. METHODS AND RESULTS: We measured serum lipoproteins, oxidized LDL, adipokines, inflammatory markers, metabolic markers, and arginine metabolites in 2,268 individuals (age 24-39 y). Participants were asked frequency, duration, and intensity of PA in leisure time. In addition, commuting to work was assessed. In both sexes, PA was inversely associated with waist circumference (all P < 0.0001). After controlling for sex, age, and waist circumference, PA was directly associated with HDL-cholesterol and apolipoprotein A1, and inversely with heart rate, smoking, oxidized LDL, apolipoprotein B, insulin, glucose, C-reactive protein, leptin, L-arginine, and phospholipase A2 activity (all P < 0.05). CONCLUSION: These population-based data are consistent with the idea that the beneficial effects of PA on CHD risk are mediated by favorable influences on several risk factors, as judged by independent relations to markers of lipoprotein metabolism, glucose metabolism, and inflammation. These associations reflect beneficial effects on cardiovascular health in both sexes and may offer mechanistic insights for the inverse association between PA and CHD.
OBJECTIVE: Physical activity (PA) may reduce the risk of coronary heart disease (CHD) by inducing beneficial changes in several risk factors. We studied the associations between PA and a range of risk markers of CHD in young adults. METHODS AND RESULTS: We measured serum lipoproteins, oxidized LDL, adipokines, inflammatory markers, metabolic markers, and arginine metabolites in 2,268 individuals (age 24-39 y). Participants were asked frequency, duration, and intensity of PA in leisure time. In addition, commuting to work was assessed. In both sexes, PA was inversely associated with waist circumference (all P < 0.0001). After controlling for sex, age, and waist circumference, PA was directly associated with HDL-cholesterol and apolipoprotein A1, and inversely with heart rate, smoking, oxidized LDL, apolipoprotein B, insulin, glucose, C-reactive protein, leptin, L-arginine, and phospholipase A2 activity (all P < 0.05). CONCLUSION: These population-based data are consistent with the idea that the beneficial effects of PA on CHD risk are mediated by favorable influences on several risk factors, as judged by independent relations to markers of lipoprotein metabolism, glucose metabolism, and inflammation. These associations reflect beneficial effects on cardiovascular health in both sexes and may offer mechanistic insights for the inverse association between PA and CHD.
Authors: Xiaolin Yang; Kaisa Kaseva; Liisa Keltikangas-Järvinen; Laura Pulkki-Råback; Mirja Hirvensalo; Markus Jokela; Mirka Hintsanen; Taina Hintsa; Anna Kankaanpää; Risto Telama; Nina Hutri-Kähönen; Jorma S A Viikari; Olli T Raitakari; Tuija Tammelin Journal: Int J Behav Med Date: 2017-04
Authors: Quan L Huynh; Christopher L Blizzard; Olli Raitakari; James E Sharman; Costan G Magnussen; Terence Dwyer; Markus Juonala; Mika Kähönen; Alison J Venn Journal: Hypertens Res Date: 2015-02-19 Impact factor: 3.872
Authors: Xiaolin Yang; Mirja Hirvensalo; Mirka Hintsanen; Taina Hintsa; Laura Pulkki-Råback; Markus Jokela; Risto Telama; Tuija Tammelin; Nina Hutri-Kähönen; Jorma S A Viikari; Olli T Raitakari Journal: Int J Behav Med Date: 2014-12
Authors: M Oikonen; M Hintsanen; M Laaksonen; V Mikkilä; M Kähönen; T Lehtimäki; L Pulkki-Råback; J S A Viikari; L Keltikangas-Järvinen; O T Raitakari Journal: Int J Behav Med Date: 2014-06
Authors: I Heinonen; H Helajärvi; K Pahkala; O J Heinonen; M Hirvensalo; K Pälve; T Tammelin; X Yang; M Juonala; V Mikkilä; M Kähönen; T Lehtimäki; J Viikari; O T Raitakari Journal: BMJ Open Date: 2013-06-20 Impact factor: 2.692
Authors: Paula Jääskeläinen; Costan G Magnussen; Katja Pahkala; Vera Mikkilä; Mika Kähönen; Matthew A Sabin; Mikael Fogelholm; Nina Hutri-Kähönen; Leena Taittonen; Risto Telama; Tomi Laitinen; Eero Jokinen; Terho Lehtimäki; Jorma S A Viikari; Olli T Raitakari; Markus Juonala Journal: Diabetes Care Date: 2012-07-18 Impact factor: 19.112
Authors: Peter Würtz; Ville-Petteri Mäkinen; Pasi Soininen; Antti J Kangas; Taru Tukiainen; Johannes Kettunen; Markku J Savolainen; Tuija Tammelin; Jorma S Viikari; Tapani Rönnemaa; Mika Kähönen; Terho Lehtimäki; Samuli Ripatti; Olli T Raitakari; Marjo-Riitta Järvelin; Mika Ala-Korpela Journal: Diabetes Date: 2012-04-17 Impact factor: 9.461
Authors: Minna K Salonen; Niko Wasenius; Eero Kajantie; Aulikki Lano; Jari Lahti; Kati Heinonen; Katri Räikkönen; Johan G Eriksson Journal: PLoS One Date: 2015-05-20 Impact factor: 3.240